Lennox-gastaut Syndrome
📧 Sign up to get email alerts when something new happens for Lennox-gastaut Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2025-09-15Clinical Trial Update: An Extended Access Program (EAP) for Perampanel
The extended access program for perampanel has ended and is no longer available.
-
CLINICAL_TRIALS withdrawal · 2024-10-03Clinical Trial Update: A Study on Dravet Syndrome (DS) and Lennox-Gastaut Syndrome (LGS) in Children, Teenagers and Adults in Portugal
A Takeda-sponsored clinical trial investigating Dravet syndrome and Lennox-Gastaut syndrome in children, teenagers and adults in Portugal ha…
-
CLINICAL_TRIALS withdrawal · 2022-07-14Clinical Trial Update: Melatonin Versus Placebo in the Lennox-Gastaut Syndrome: Neurophysiological and Neuropsychological Effects [Phase 4]
Phase 4 trial of melatonin vs placebo in Lennox-Gastaut syndrome was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2018-04-30Clinical Trial Update: Turmeric as Treatment in Epilepsy [NA]
A clinical trial evaluating turmeric as a treatment for epilepsy has been withdrawn, including conditions such as Dravet syndrome, Lennox-Ga…
-
CLINICAL_TRIALS withdrawal · 2018-01-04Clinical Trial Update: Cannabidiol Oral Solution as an Adjunctive Therapy for Treatment of Participants With Inadequately Controlled Lennox-Gastaut Syndrome [Phase 3]
A Phase 3 trial of cannabidiol oral solution as adjunctive therapy for Lennox-Gastaut Syndrome was withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.